DABUR Dabur India Q3 FY25 results (Oct–Dec 2024) and concall
Dabur India reported a mixed Q3 FY25, with consolidated revenue growing 3.1% (INR) and 5.6% (constant currency) amidst a challenging demand environment and delayed winters. International business and HPC (especially Oral Care and Home Care) showed strong growth, while Healthcare and Beverages faced headwinds. The company is undertaking strategic initiatives, including a partnership with McKinsey, to refine its vision and address category-specific challenges, aiming for sequential improvement in demand and margin expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 2,144 | 2,448 |
| EBITDA | 403 | 523 |
| Net profit | 329 | 418 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
